facebook Twitter Instagram YouTube
 
Press Releases
Press Release
May 4th, 2020
CSL Behring is Committed to Supporting Patients

CSL Behring is committed to supporting patients. We are a company known for keeping our promises, and our promise goes beyond producing life-saving products. We also aim to make sure that nothing holds patients back from getting the therapies they need – including financial or insurance challenges. We are here to help.

HAEGARDA Connect offers many resources in one place to provide assistance, information, and support—all with a single phone call. Care Coordinators provide personalized patient support with insurance benefits investigation, navigating the process of prior authorizations, nursing services for self-administration training and research into financial assistance options, such as:

  • Co-pay program eligibility for commercially insured patients to cover the cost of insurance co-pays for HAEGARDA at 100%, up to the program maximum
  • HAEGARDA bridge program, temporary assistance for those who experience a gap in insurance coverage

Contact HAEGARDA Connect today at 1-844-HAEGARDA (1-844-423-4273) from 8AM-8PM ET.

https://www.haegarda.com

BERINERT Connect is also available providing patient support throughout the insurance process and with research into financial assistance options such as:

  • Co-pay program eligibility for commercially insured patients to cover the cost of insurance co-pays for BERINERT up to the program maximum

Contact Berinert Connect at 1-877-236-4HAE (1-877-236-4423) from 8AM-8PM ET.

https://www.berinert.com  

In addition, the CSL Behring Patient Assistance Program provides access to CSL Behring therapies for qualified patients who are uninsured or underinsured.

CSL Behring remains committed to our patients and the rare-disease communities we serve.